Creatine phosphate: an additive to cardioplegic solutions. Clinical study
D'Alessandro, L.C.; Cini, R.; Stazi, G.; Pucci, A.; De Benedictis, F.; Rabitti, G.; Benhar, M.; Giacopino, F.; Pezza, E.; Cioli, G.
Cardiologia 32(3): 307-313
1987
ISSN/ISBN: 0393-1978 PMID: 3607801 Document Number: 300835
Document emailed within 1 workday
Related Documents
Ishikura, Y.; Odagiri, S.; Shimazu, A.; Hirao, D.; Watanabe, H.; Hatooka, S.; Hamada, M. 1992: Clinical evaluation of myocardial protection by oxygenated crystalloid cardioplegic solutions with DBcAMP Nihon Geka Gakkai Zasshi 93(6): 632-638Shikano, K.; Nasu, M.; Miyamura, K.; Sakai, T.; Shomura, S.; Kusagawa, M.; Hidaka, H. 1984: Experimental study on the effects of compositions of cardioplegic solutions on coronary arteries Nihon Kyobu Geka Gakkai 32(3): 294-300
Menasche, P.; Groussett, C.; Piwnica, A. 1983: Ionic bases of cardioplegic solutions. II. Influence of the ionic composition of a cardioplegic solution on the metabolic and functional preservation of ischemic myocardium. Experimental evaluation with phosphorus 31 nuclear magnetic resonance and applications to cardiac surgery Archives des Maladies du Coeur et des Vaisseaux 76(12): 1465-1474
Davydov, V.V.; Tverdokhlib, V.P.; Iakushev, V.S. 1983: Creatine phosphate content and creatine phosphokinase activity in the cardiomyocyte mitochondria in myocardial infarct in rats subjected to emotional and pain stress Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 1: 33-36
Williams, G.D.; Enders, B.; Smith, M.B. 1992: Effect of pH and inorganic phosphate on creatine kinase inactivation: an in vitro 31P NMR saturation-transfer study Biochemistry International 26(1): 35-42
Meerson, F.Z.; Golubeva, L.Iu.; Lakomkin, V.L.; Dvoriantsev, S.N.; Stepanov, V.A. 1993: The effect of adaptation to repeated stresses on the recovery of cardiac function and creatine phosphate after total ischemia (a 31P-NMR study) Biulleten' Eksperimental'noi Biologii i Meditsiny 115(6): 569-572
Yu, G.; Ye, D. 1990: Optimal potassium concentration in cardioplegic solutions Zhonghua Xin Xue Guan Bing Za Zhi 18(1): 42-6 62
Salerno, T.A.; Chiong, M.A. 1980: Cardioplegic arrest in pigs. Effects of glucose-containing solutions Journal of Thoracic and Cardiovascular Surgery 80(6): 929-933
Onishchenko, N.A.; Lubiako, A.A. 1985: Anti-ischemic protection of the myocardium by cardioplegic solutions Vestnik Akademii Meditsinskikh Nauk SSSR 1985(4): 40-47
Horikoshi, S. 1987: A new approach to infusion of cardioplegic solutions in Cabrol technic Kyobu Geka. Japanese Journal of Thoracic Surgery 40(11): 900-901
Dias, R.R.; Stolf, N.A.G.; Dalva, M.; Dias, A.R.; Moreira, L.F.P.; Oliveira, S.A. 2004: Inclusion of lidocaine in cardioplegic solutions provides additional myocardial protection Journal of Cardiovascular Surgery 45(6): 551-555
Pereira, S.N.; Ribeiro, C.T.; Raiser, A.G.; Tabone, E.J.; Andujar, M.B.; Marques, R.S. 1983: Myocardial protection in cardiac surgery. Comparison of 2 cardioplegic solutions Arquivos Brasileiros de Cardiologia 40(4): 255-258
Rousou, J.A.; Engelman, R.M.; Breyer, R.H.; Otani, H.; Lemeshow, S.; Das, D.K. 1988: The effect of temperature and hematocrit level of oxygenated cardioplegic solutions on myocardial preservation Journal of Thoracic and Cardiovascular Surgery 95(4): 625-630
Carrier, M.; Khalil, A.; Tourigny, A.; Solymoss, B.C.; Pelletier, L.C. 1996: Metabolic recovery after global myocardial ischemia: effects of blood cardioplegic solutions Canadian Journal of Cardiology 12(6): 607-611
Chong, Y.S.; Cottier, D.S.; Gavin, J.B. 1994: Myocardial protection during prolonged ischaemic cardiac arrest: experimental evaluation of three crystalloid cardioplegic solutions Journal of Cardiovascular Surgery 35(1): 35-44
Timmermans, J.A.; Bindels, R.J.; Van Os, C.H. 1995: Stimulation of plasma membrane Ca2+ pump by calbindin-D28k and calmodulin is additive in EGTA-free solutions Journal of Nutrition 125(7 Suppl): 1981s-1986s
Takahashi, A.; Hearse, D.J.; Braimbridge, M.V.; Chambers, D.J. 1990: Harvesting hearts for long-term preservation. Detrimental effects of initial hypothermic infusion of cardioplegic solutions Journal of Thoracic and Cardiovascular Surgery 100(3): 371-378
Natsuaki, M.; Itoh, T.; Tomita, S.; Yoshikai, M.; Norita, H.; Suda, H. 1995: Clinical study on the ideal temperature of blood cardioplegic solution in coronary artery bypass graft surgery Nihon Kyobu Geka Gakkai 43(7): 990-996
Hessov, I.; Jacobsen, M.K.; Pinholt, H. 1980: Contamination of glucose solutions in a surgical ward. Study of the frequency of contamination following addition of a phosphate buffer Ugeskrift for Laeger 142(11): 696-697
Böswart, J.; Krausová, M. 1982: Creatine phosphate in the blood during physical loading Casopis Lekaru Ceskych 121(40): 1221-1224